Last reviewed · How we verify
Neonatal Hemorrhagic Disease
Approved treatments
- phytomenadione · Instituto Mexicano del Seguro Social
- Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neonatal Hemorrhagic Disease patent landscape — cliff calendar, originator estates, attackable patents
- Neonatal Hemorrhagic Disease treatment landscape brief
- Neonatal Hemorrhagic Disease treatment updates RSS
Frequently asked questions about Neonatal Hemorrhagic Disease
What drugs treat Neonatal Hemorrhagic Disease?
Tracked treatments include phytomenadione, Phylloquinone.
What is the treatment for Neonatal Hemorrhagic Disease?
Standard treatment for Neonatal Hemorrhagic Disease includes phytomenadione, Phylloquinone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neonatal Hemorrhagic Disease patent cliff · Neonatal Hemorrhagic Disease CI report
- Treatment: phytomenadione · Instituto Mexicano del Seguro Social
- Treatment: Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing